Global Patient Blood Management Market

Patient Blood Management Market Size, Share, Growth Analysis, By Type(Instruments, Software and Consumables), By Application(Preoperative Anemia Management, Acute Blood Loss Management and Chronic Blood Loss Management), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2100 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 61 | Figures: 75

Patient Blood Management Market Insights

Patient Blood Management Market size was valued at USD 12.97 billion in 2022 and is poised to grow from USD 13.79 billion in 2023 to USD 22.48 billion by 2031, growing at a CAGR of 6.30% during the forecast period (2024-2031).

The global patient blood management market is experiencing significant growth, driven by various factors such as the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness about the benefits of patient blood management strategies. Patient blood management (PBM) involves a comprehensive approach to optimize the care of patients who might need blood transfusion, aiming to improve patient outcomes and reduce the need for blood transfusions whenever possible. One of the key drivers of the global market is the rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and blood disorders. These conditions often require surgical interventions, which may involve the need for blood transfusions. However, healthcare providers are increasingly adopting patient blood management strategies to minimize the use of blood transfusions, as they are associated with risks and complications. This trend is fueling the demand for patient blood management solutions and services. The emphasis on improving surgical outcomes, reducing complications, and shortening hospital stays is driving the adoption of patient blood management protocols, leading to market growth. Blood transfusions are associated with various risks, including infections, immune reactions, and transfusion-related complications. Patient blood management offers a holistic approach to patient care, focusing on alternatives to transfusions, such as optimizing the patient's own blood volume, reducing blood loss during surgery, and employing pharmacological and non-pharmacological methods to enhance the patient's tolerance to anemia. Increasing awareness about these strategies is driving the adoption of patient blood management practices globally.

US Patient Blood Management Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Patient Blood Management Market size was valued at USD 12.97 billion in 2022 and is poised to grow from USD 13.79 billion in 2023 to USD 22.48 billion by 2031, growing at a CAGR of 6.30% during the forecast period (2024-2031).

The global patient blood management market is highly competitive and dynamic, characterized by the presence of several key players operating in the healthcare industry. Patient blood management refers to a multidisciplinary approach that aims to optimize patient outcomes by effectively managing and preserving the patient's own blood. This includes strategies such as minimizing blood loss, optimizing red blood cell production, and utilizing alternative therapies to transfusion. 'Fresenius SE & Co. KGaA (Germany)', 'Haemonetics Corporation (US)', 'Terumo Corporation (Japan)', 'B. Braun Melsungen AG (Germany)', 'Bio-Rad Laboratories, Inc. (US)', 'LivaNova PLC (UK)', 'Medtronic PLC (Ireland)', 'Abbott Laboratories (US)', 'Grifols, S.A. (Spain)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Danaher Corporation (US)', 'Immucor, Inc. (US)', 'BioMérieux SA (France)', 'Ortho Clinical Diagnostics (US)', 'Fresenius Kabi AG (Germany)', 'Kedrion S.p.A. (Italy)', 'Octapharma AG (Switzerland)', 'Beckman Coulter, Inc. (US)', 'Siemens Healthineers AG (Germany)', 'Quidel Corporation (US)'

The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

One significant market trend in the global patient blood management market is the increasing focus on personalized and evidence-based approaches to optimize blood transfusion practices. This trend emphasizes the importance of tailoring blood transfusion strategies to individual patients based on their specific needs and clinical conditions, rather than adopting a one-size-fits-all approach. Healthcare providers and organizations are recognizing the potential risks and complications associated with unnecessary blood transfusions, such as transfusion reactions, infections, and increased healthcare costs.

North America dominated the global patient blood management market. North America holds a significant share in the market due to the presence of advanced healthcare infrastructure, well-established healthcare systems, and a high level of awareness about patient blood management practices. Countries like the US and Canada have implemented stringent regulations and guidelines to promote safe and effective blood management, driving the market growth in the region. Additionally, technological advancements and a strong focus on research and development contribute to the dominance of North America in the patient blood management market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Patient Blood Management Market

Report ID: SQMIG35D2100

$5,300
BUY NOW GET FREE SAMPLE